Mesa-Valle C M, Castilla-Calvente J, Sanchez-Moreno M, Moraleda-Lindez V, Barbe J, Osuna A
Departamento de Biología Aplicada, Universidad de Almeria, Spain.
Antimicrob Agents Chemother. 1996 Mar;40(3):684-90. doi: 10.1128/AAC.40.3.684.
In the present work, we have assayed both the in vitro and in vivo action of two acridine compounds against Leishmania donovani. As part of this effort, we have studied the possible action mechanism of these compounds at the ultrastructural and biochemical levels and in relation to the synthesis of macromolecules. The two acridinones inhibit the in vitro growth of the promastigote forms of L. donovani at the highest concentration assayed (100 micrograms/ml). The in vivo results indicate that both compounds reduce the number of amastigotes per gram of spleen, and decrease parasitism, by more than 40%. With respect to the action mechanism, both compounds inhibit the incorporation of [3H]thymidine, inducing alterations at the ultrastructural level in the DNA and mitochondria. Alterations are also caused in the enzymes of the Krebs cycle.
在本研究中,我们检测了两种吖啶化合物对杜氏利什曼原虫的体外和体内作用。作为这项工作的一部分,我们在超微结构和生化水平上以及与大分子合成相关的方面研究了这些化合物可能的作用机制。这两种吖啶酮在检测的最高浓度(100微克/毫升)下抑制杜氏利什曼原虫前鞭毛体形式的体外生长。体内结果表明,这两种化合物均使每克脾脏中的无鞭毛体数量减少,并使寄生虫感染率降低40%以上。关于作用机制,这两种化合物均抑制[3H]胸腺嘧啶核苷的掺入,在DNA和线粒体的超微结构水平上引起改变。三羧酸循环的酶也会发生改变。